university website

H.J.F. van Hoogstraten (Hubert), F.H.J. Wolfhagen (Franciscus), P.C. van de Meeberg (Paul), H. Kuiper (Hillechien), G.A.J.J. Nix (Gerard), M.C.J.M. Becx (Marco), A.C. Hoek (Aad), D.P.F. van Houte (D. P F), M.C.M. Rijk, J.M. Salemans (Jan), et al. J. Scherpenisse (Joost), M. Schrijver (Max), A.M. Smit (A.), P. Spoelstra (Pieter), R. Stadhouders (Ralph), T. Tan Gie (T.), W.C.J. Hop (Wim), F.J.W. ten Kate (Fiebo), G.P. VanBerge-Henegouwen (Gerard), S.W. Schalm (Solko), H.R. van Buuren (Henk) and H.R. van Buuren (Henk)

1998-09-01

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

Publication

Publication

Journal of Hepatology , Volume 29 - Issue 3 p. 417- 423

Additional Metadata
Keywords Bile acid therapy, Cholestatic liver disease, Dose regimen, Histology, Survival
Persistent URL doi.org/10.1016/S0168-8278(98)80059-7, hdl.handle.net/1765/68742
Journal Journal of Hepatology
Organisation Department of Pathology
Citation
van Hoogstraten, H.J.F, Wolfhagen, F.H.J, van de Meeberg, P.C, Kuiper, H, Nix, G.A.J.J, Becx, M.C.J.M, … van Buuren, H.R. (1998). Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses. Journal of Hepatology, 29(3), 417–423. doi:10.1016/S0168-8278(98)80059-7


User Publication Person Organisation Collection
Close